216 related articles for article (PubMed ID: 4081224)
1. [Evaluation of vaccination policies. The case of measles].
Lafarge H; Levy E; Rey M
Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
[TBL] [Abstract][Full Text] [Related]
2. [Costs and benefits of measles vaccination].
Ambrosch F; Wiedermann G; Harasek G
Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological study and cost evaluation of measles in Lyons hospitals over a 5-year period].
Loras-Duclaux I; David L; Peyramond D; Floret D; Lachaux A; Hermier M
Pediatrie; 1988; 43(5):451-4. PubMed ID: 3200658
[TBL] [Abstract][Full Text] [Related]
4. [The eradication of measles by general vaccination is beneficial and feasible].
Rey M
Ann Pediatr (Paris); 1984 Jun; 31(6):483-7. PubMed ID: 6380378
[No Abstract] [Full Text] [Related]
5. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
[TBL] [Abstract][Full Text] [Related]
6. Measles control in developing and developed countries: the case for a two-dose policy.
Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
[TBL] [Abstract][Full Text] [Related]
7. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
Grabowsky M; Nobiya T; Ahun M; Donna R; Lengor M; Zimmerman D; Ladd H; Hoekstra E; Bello A; Baffoe-Wilmot A; Amofah G
Bull World Health Organ; 2005 Mar; 83(3):195-201. PubMed ID: 15798843
[TBL] [Abstract][Full Text] [Related]
8. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
[TBL] [Abstract][Full Text] [Related]
9. Two-dose measles vaccination schedules.
Rosenthal SR; Clements CJ
Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
[TBL] [Abstract][Full Text] [Related]
10. Current impact of measles in Latin America.
Borgoño JM
Rev Infect Dis; 1983; 5(3):417-21. PubMed ID: 6878992
[TBL] [Abstract][Full Text] [Related]
11. [Measles in the Local Health Unit Naples 4: vaccination coverage, epidemic 2001-2002 and prevention strategies].
Gigli L; Graziano M; Manetta G; Palombino R
Ann Ig; 2004; 16(5):627-32. PubMed ID: 15552728
[TBL] [Abstract][Full Text] [Related]
12. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
[TBL] [Abstract][Full Text] [Related]
13. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
14. [Vaccination against measles. The situation in Mexico and America. Advances in the method of aerosol immunization].
Fernández de Castro J; Kumate J
Bol Med Hosp Infant Mex; 1990 Jul; 47(7):449-61. PubMed ID: 2206410
[TBL] [Abstract][Full Text] [Related]
15. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
16. Strategic planning for measles control: using data to inform optimal vaccination strategies.
Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
[TBL] [Abstract][Full Text] [Related]
17. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
Yuan L
CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
[TBL] [Abstract][Full Text] [Related]
18. [Estimate of the cost/benefit ratio of measles vaccination].
Cárdenas Ayala VM; Ruiz Matus C; Cabrera Coello L; Montesano Castellanos R; Garrido Lozada MT; Olvera Castillo R; Díaz Ortega JL
Salud Publica Mex; 1989; 31(6):735-44. PubMed ID: 2516660
[TBL] [Abstract][Full Text] [Related]
19. [The social impact of the vaccination against measles in Mexico. Comments during the course of the epidemics of 1988-1990].
Cárdenas-Ayala VM; Sánchez-Vargas C
Bol Med Hosp Infant Mex; 1990 Jul; 47(7):500-5. PubMed ID: 2206416
[TBL] [Abstract][Full Text] [Related]
20. Progress in the control of measles in Ghana, 1980-2000.
Bosu WK; Essel-Ahun M; Adjei S; Strebel P
J Infect Dis; 2003 May; 187 Suppl 1():S44-50. PubMed ID: 12721890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
